Introduction Non-Small Cell Lung Cancer (NSCLC) is the most prevalent form of lung cancer, accounting for approximately 85% of all lung cancer cases. Despite advancements in treatment, NSCLC remains a leading cause of cancer-related mortality worldwide. In recent years, Cuba has emerged as a significant contributor to innovative NSCLC therapies, particularly through the development of...